Skip to main content

Published locations for ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patients

User login

  • Reset your password
  • /content/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer-patients
  • /clinicianreviews/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer
  • /fedprac/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer-patients
  • /hematologynews/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer
  • /internalmedicinenews/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory
  • /oncologypractice/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer
  • /vascularspecialistonline/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence
  • /fedprac/avaho/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer
  • /hematology-oncology/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory
  • /hematologytimes/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer
  • /ecardiologynews/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer
  • /cardiology/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer
  • /internalmedicine/article/194780/thrombosis/icymi-rivaroxaban-reduces-vte-incidence-ambulatory-cancer